StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.11−0.04 (-3.48%)

Close on Nov 18, 2026Market cap $80.25MP/E –Yield –

InflaRx operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2023 it was -€44.91M.

Annual operating income

PeriodPeriod endValueChange
FY2023Dec 31, 2023-€44.91M–
FY2022Dec 31, 2022-€32.24M–
FY2021Dec 31, 2021-€47.63M–

More InflaRx figures

See a number that looks wrong?